Scarica l'app Stockscreener
6.36
6.33%
-0.43
Dopo l'orario di chiusura:
6.15
-0.21
-3.30%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RXRX Giù?
Forum
Previsione
Precedente Chiudi:
$6.79
Aprire:
$6.79
Volume 24 ore:
228.60M
Relative Volume:
6.63
Capitalizzazione di mercato:
$2.72B
Reddito:
$64.60M
Utile/perdita netta:
$-377.75M
Rapporto P/E:
-4.1032
EPS:
-1.55
Flusso di cassa netto:
$-335.64M
1 W Prestazione:
+7.61%
1M Prestazione:
+31.40%
6M Prestazione:
+19.55%
1 anno Prestazione:
-9.27%
Intervallo 1D:
$6.25
$7.04
Intervallo di 1 settimana:
$5.07
$7.04
Portata 52W:
$3.79
$12.36
Recursion Pharmaceuticals Inc Stock (RXRX) Company Profile
Nome
Recursion Pharmaceuticals Inc
Settore
Industria
Telefono
(385) 269-0203
Indirizzo
41S RIO GRANDE STREET, SALT LAKE CITY
Confronta RXRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RXRX
Recursion Pharmaceuticals Inc
|
6.36 | 2.57B | 64.60M | -377.75M | -335.64M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Recursion Pharmaceuticals Inc Stock (RXRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-03 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-05-22 | Iniziato | Morgan Stanley | Equal-Weight |
| 2023-03-16 | Iniziato | Needham | Buy |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2022-04-18 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-03-04 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2021-09-21 | Iniziato | Berenberg | Buy |
| 2021-05-11 | Iniziato | BofA Securities | Buy |
| 2021-05-11 | Iniziato | Goldman | Neutral |
| 2021-05-11 | Iniziato | JP Morgan | Neutral |
| 2021-05-11 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2021-05-11 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Recursion Pharmaceuticals Inc Borsa (RXRX) Ultime notizie
Recursion Pharmaceuticals (RXRX) Suffers a Larger Drop Than the General Market: Key Insights - Nasdaq
Recursion (RXRX) Stock Surges on AI-Driven Breakthroughs and Big-Pharma Deals - ts2.tech
Recursion Pharmaceuticals (RXRX) Extends Gains, Jumps 15.28% on Major AI Event - MSN
Is Recursion Pharmaceuticals a Millionaire Maker? - The Motley Fool
Recursion Pharma (RXRX) Stock Jumps as AI Drug Discovery Hype Builds - parameter.io
Recursion Pharmaceuticals’ Stock Soars Amid Investor Optimism - TipRanks
Will Recursion Pharmaceuticals Inc. stock maintain growth storyEarnings Growth Report & High Return Stock Watch Alerts - newser.com
Recursion RXRX Stock Skyrockets: AI Breakthroughs and Big Pharma Deals Ignite Biotech Surge - ts2.tech
When is the best time to exit Recursion Pharmaceuticals Inc.Market Movers & Real-Time Buy Zone Alerts - newser.com
RXRX’s Big Leap: Worries Over? - StocksToTrade
Evaxion (NASDAQ:EVAX) Stock Rockets After AI-Powered Cancer Vaccine Breakthrough - ts2.tech
Recursion Pharmaceuticals Inc. stock volume spike explained2025 Key Lessons & Step-by-Step Trade Execution Guides - newser.com
Signal strength of Recursion Pharmaceuticals Inc. stock in tech scannersTrade Performance Summary & AI Forecast for Swing Trade Picks - newser.com
Best Biotech Stocks To Follow NowOctober 10th - MarketBeat
How to recover losses in Recursion Pharmaceuticals Inc. stock2025 Breakouts & Breakdowns & Verified Entry Point Detection - newser.com
Recursion Surge: Is Now the Perfect Time to Consider? - timothysykes.com
Recursion Pharmaceuticals Stock (RXRX) Opinions on Recent Price Momentum - Quiver Quantitative
Absci Stock Offers High-Risk AI Biotech Exposure With 110% Upside Forecast - Investing.com
Will Recursion Pharmaceuticals Inc. stock recover faster than marketWall Street Watch & Low Risk Entry Point Guides - newser.com
Advanced analytics toolkit walkthrough for Recursion Pharmaceuticals Inc.Weekly Market Report & Daily Profit Maximizing Trade Tips - newser.com
Is Recursion Pharmaceuticals on a Comeback Trail? - StocksToTrade
Best Biotech Stocks To ConsiderOctober 9th - MarketBeat
Biotech Stocks To ResearchOctober 13th - MarketBeat
Using economic indicators to assess Recursion Pharmaceuticals Inc. potentialJuly 2025 Patterns & Free Fast Entry Momentum Trade Alerts - newser.com
Recursion Pharmaceuticals Hits Day High with 16.44% Surge in Stock Price - Markets Mojo
Costco, AMD, Recursion Pharmaceuticals, Cipher Mining And Snowflake: Why These 5 Stocks Are On Investors' Radars Today - AOL.com
Promising Biotech Stocks To Follow NowOctober 11th - MarketBeat
Recursion Pharmaceuticals (RXRX): Assessing Valuation with AI Strategy in Focus Ahead of Key CEO Presentation - Yahoo Finance
Where Will Recursion Pharmaceuticals Be in 5 Years? - MSN
How Investors Are Reacting To Recursion Pharmaceuticals (RXRX) AI Platform Spotlight Ahead of CEO's Dubai Talk - simplywall.st
Biotech Stocks To Follow TodayOctober 8th - MarketBeat
RXRX Stock: What’s Behind Recent Moves? - timothysykes.com
Recursion Pharmaceuticals (RXRX): Evaluating Valuation Ahead of CEO’s AI Conference Appearance and Growth Plans - simplywall.st
Recursion Stock: Can It Bounce Back? - StocksToTrade
Recursion Pharmaceuticals’ Stocks: A Deep Dive - timothysykes.com
Assessing Recursion Pharmaceuticals After Shares Surge 19% Amid AI-Driven Market Optimism - simplywall.st
Recursion Pharmaceuticals: Recent Gains Mysterious Given Lack Of Overall Progress (RXRX) - Seeking Alpha
AI Drug Discovery Goldmine? Inside Recursion Pharma’s Wild Stock Surge and What’s Next - ts2.tech
Weiss Ratings Reiterates "Sell (D-)" Rating for Recursion Pharmaceuticals (NASDAQ:RXRX) - MarketBeat
Recursion Pharmaceuticals (RXRX) Climbs 16% Ahead of AI Conference - Yahoo Finance
Why Recursion Pharmaceuticals Stock Tanked on Tuesday - MSN
COST, AMD, RXRX, CIFR, SNOW: 5 Trending Stocks TodayAdvanced Micro Devices (NASDAQ:AMD) - Benzinga
Best Pharmaceutical Stocks To Watch NowOctober 8th - MarketBeat
What's Going On With Recursion Pharmaceuticals Stock On Wednesday? - Benzinga
Investors Buy Large Volume of Recursion Pharmaceuticals Call Options (NASDAQ:RXRX) - MarketBeat
Recursion Pharmaceuticals (NASDAQ:RXRX) Trading Up 5.8%Here's What Happened - MarketBeat
Recursion Pharmaceuticals Inc Azioni (RXRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):